CorMedix (CRMD) EBIT Growth (3y) (2013 - 2025)
CorMedix (CRMD) EBIT Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
-92.14% |
| Date | Value |
|---|
| Dec 31, 2025 |
-92.14% |
| Sep 30, 2025 |
110.86% |
| Jun 30, 2025 |
63.51% |
| Mar 31, 2025 |
69.41% |
| Dec 31, 2024 |
81.86% |
| Sep 30, 2024 |
27.33% |
| Jun 30, 2024 |
-37.53% |
| Mar 31, 2024 |
-32.32% |
| Dec 31, 2023 |
-37.07% |
| Sep 30, 2023 |
-16.60% |
| Jun 30, 2023 |
-9.79% |
| Mar 31, 2023 |
-25.22% |
| Dec 31, 2022 |
-15.99% |
| Sep 30, 2022 |
-10.42% |
| Jun 30, 2022 |
-14.17% |
| Mar 31, 2022 |
-12.62% |
| Dec 31, 2021 |
-77.99% |
| Sep 30, 2021 |
5.78% |
| Jun 30, 2021 |
11.80% |
| Mar 31, 2021 |
10.89% |
